Skip to main content
×
×
Home

Serotonin syndrome

  • Shameem Mir and David Taylor (a1)
Abstract
Aims and method

To define serotonin syndrome and its symptoms and to discover which drugs or drug combinations are likely to cause it. A review of literature (including case reports) relating to serotonin syndrome collated from searches of MedLine and Micromedex covering the period January 1991 to July 1998.

Results

Most of the data found were either individual case reports or reviews of case reports. Reports of serotonin syndrome seem to be growing, certainly since the introduction of selective serotonin reuptake inhibitors. Particular combinations seem most likely to induce serotonin syndrome. Awareness of this syndrome as a distinct clinical entity seems to be growing.

Clinical implications

Serotonin syndrome is more likely to occur with drug combinations, especially those involving monoamine oxidase inhibitors. It can also occur when swapping antidepressant therapy, especially If changing from a long acting antidepressant such as fluoxetine. Caution is needed when changing antidepressants and particularly when they are used in combination.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Serotonin syndrome
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Serotonin syndrome
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Serotonin syndrome
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Corresponding author
Correspondence
References
Hide All
Alderman, C. P. & Lee, P. C. (1996) Comment: serotonin syndrome associated with combined sertraline–amitriptyline treatment. Annals of Pharmacotherapy, 30, 1499 1500.
Benazzi, F. (1996) Serotonin syndrome with moclobemide–fluoxetine combination. Pharmacopsychiatry, 29, 162.
Bhatara, V. (1994) Venlafaxine–fluoxetine interaction? Current Affective Illness, 13, 14.
Bhatara, V. & Bandettini, F. (1993) Serotonin syndrome and interactions. Clinical Pharmacology Therapeutics, 1, 84 88.
Bhatara, V., Magnus, R. D., Paul, K. L., et al (1998) Serotonin syndrome induced by venlafaxine and fluoxetine: A case study in polypharmacy and potential pharmacodynamic and pharmacokinetic mechanisms. Annals of Pharmacotherapy, 32, 432 436.
Brazelton, T., Blanc, P. D., Olson, K. R., et al (1997) Annals of Emergency Medicine, 30, 550 551.
Brown, T., Skop, B. P. & Mareth, T. R. (1996) Pathophysiology and management of the serotonin syndrome. Annals of Pharmacotherapy, 30, 527 533.
Brubacher, J. R., Hoffman, R. S. & Lurin, M. J. (1996) Serotonin syndrome from venlafaxine–tranylcypromine interaction. Veterinary and Human Toxicology, 38, 358 361.
Demirkiran, K., Jankovic, J. & Dean, J. M. (1996) Ecstasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndrome. Clinical Neuropharmacology, 19, 157 164.
Diamond, S., Pepper, B. J., Diamond, M. L., et al (1998) Serotonin syndrome induced by transitioning from phenelzine to venlafaxine: four patient reports. Neurology, 51, 274 276.
Dingemanse, J., Wallnofer, A., Gieschke, R., et al (1998) Pharmacokinetic and pharmacodynamic interactions between fluoxetine and moclobemide in the investigation of development of the ‘serotonin syndrome’, Clinical Pharmacology Therapeutics, 63, 403 413.
Egberts, A. C. G., Ter Borgh, J. & Meijer-Brodie, C. C. E. (1997) Serotonin syndrome attributed to tramadol addition to paroxetine therapy. International Clinical Psychopharmacology, 12, 181 182.
Fink, M. (1996) Toxic serotonin syndrome or neuroleptic malignant syndrome? Pharmacopsychiatry, 29, 159 161.
Francois, B., Marquet, P., Desachy, A., et al (1997) Serotonin syndrome due to an overdose of moclobemide and clomipramine. A potentially life-threatening association. Intensive Care Medicine, 23, 122 124.
Gardner, D. M. & Lynd, L. D. (1998) Sumatriptan contraindications and the serotonin syndrome. Annals of Pharmacotherapy, 32, 33 38.
Gillman, P. K. (1997) Serotonin syndrome – clomipramine too soon after moclobemide. International Clinical Psychopharmacology, 12, 339 342.
Gillman, P. K. (1999) The serotonin syndrome and its treatment. Journal of Psychopharmacology, 13, 100 109.
Gitlin, M. J. (1997) Venlafaxine, monoamine oxidase inhibitors, and the serotonin syndrome. Journal of Clinical Psychopharmacology, 17, 66 67.
Hilton, S. E., Maradit, H. & Moller, H. J. (1997) Serotonin syndrome and drug combinations: focus on MAOI and REMA. European Archives of Psychiatry and Clinical Neurosciences, 247, 113 119.
Hodgman, M. J., Martin, T. G. & Krenzelok, E. P. (1997) Serotonin syndrome due to venlafaxine and maintenance tranylcypromine therapy. Human and Experimental Toxicology, 16, 14 17.
John, L., Perreault, M. M., Tao, T., et al (1997) Serotonin syndrome associated with nefazodone and paroxetine. Annals of Emergency Medicine, 29, 287 289.
Lane, R. & Baldwin, D. (1997) Selective serotonin reuptake inhibitor-induced serotonin syndrome: Review. Journal of Clinical Psychopharmacology, 17, 208 221.
Lejoyeux, M., Ades, J. & Rouillon, F. (1994) Serotonin syndrome. Incidence, symptoms and treatments. CNS Drugs, 2, 132 143.
Mason, B. J. & Blackburn, K. H. (1997) Possible serotonin syndrome associated with tramadol and sertraline coadministration. Annals of Pharmacotherapy, 31, 175 177.
Mekler, G. & Woggon, B. (1997) A case of serotonin syndrome caused by venlafaxine and lithium. Pharmacopsychiatry, 30, 272 273.
Mills, K. C. (1995) Serotonin syndrome. American Family Physician, 52, 1475 1482.
Mueller, P. D. & Korey, W. S. (1998) Death by ‘ecstasy’: the serotonin syndrome? Annals of Emergency Medicine, 32, 377 380.
Muly, C. E., McDonald, W., Steffens, D., et al (1993) Serotonin syndrome produced by a combination of fluoxetine and lithium. American Journal of Psychiatry, 150, 1565.
Nierenberg, D. W. & Semprebon, M. (1993) The central nervous system serotonin syndrome. Clinical Pharmacology Therapeutics, 53, 84–38.
Neuvonen, P. J., Pohjota-Sintonen, S., Tacka, U., et al (1993) Five fatal cases of serotonin syndromes after moclobemide–citalopram or moclobemide–clomipramine overdoses. Lancet, 342, 1419.
Nisijima, K., Shimizu, M., Abe, T., et al (1996) A case of serotonin syndrome induced by concomitant treatment with low-dose trazodone and amitriptyline and lithium. International Clinical Psychopharmacology, 11, 289 290.
Rosebush, P. I. & Margetts, P. (1999) Serotonin syndrome as a result of clomipramine monotherapy. Journal of Clinical Psychopharmacology, 19, 285 287.
Roxanas, M. G. & Machado, J. F. D. (1998) Serotonin syndrome in combined moclobemide and venlafaxine ingestion. Medical Journal of Australia, 168, 523 524.
Singer, P. P. & Jones, G. R. (1997) An uncommon fatality due to moclobemide and paroxetine, Journal of Analytical Toxicology, 21, 518 520.
Sobanski, T., Bagli, M., Laux, G., et al (1997) Serotonin syndrome after lithium add-on medication to paroxetine. Pharmacopsychiatry, 30, 106 107.
Spigset, O. & Mjorn-Dal, T. (1993) Serotonin syndrome caused by a moclobemide–clomipramine interaction. British Medical Journal 306, 248.
Sternbach, H. (1991) The serotonin syndrome. American Journal of Psychiatry, 148, 705 713.
Taylor, D. (1995) Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination: Interactions and therapeutic uses. British Journal of Psychiatry, 167, 575 580.
Weiner, L. A., Smythe, M. & Cisek, J. (1998) Serotonin syndrome secondary to phenelzine–venlafaxine interaction. Pharmacotherapy, 18, 399 403.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 0955-6036
  • EISSN: 1472-1473
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 6 *
Loading metrics...

Abstract views

Total abstract views: 16 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 17th July 2018. This data will be updated every 24 hours.

Serotonin syndrome

  • Shameem Mir and David Taylor (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *